MedTrace Logo

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

NCT06444607 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-21

No results posted yet for this study

Summary

In this study, the investigators are examining the role of the immune system in pheochromocytoma and paraganglioma. The investigators aim to examine the differences in the immune system between people who have these tumors with and without a hereditary predisposition. The investigators also want to see how the immune system changes during the development of the tumor in people with a hereditary predisposition. Finally, the investigators will compare the data with a control group of people without these tumors. Ultimately, the investigators hope that the results will contribute to the discovery of new immune system-targeted medications for pheochromocytoma and paraganglioma.

Conditions

  • Pheochromocytoma
  • Paraganglioma

Interventions

PROCEDURE

Venepuncture

Blood draw in the context of routine patient care, when a venipuncture is already scheduled.

PROCEDURE

Venepuncture

Volunteering for blood draw.

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Margo Dona, PhD · Radboud University Medical Center

  • Henri Timmers, M.D. PhD · Radboud University Medical Center

  • Romana Netea-Maier, M.D. PhD · Radboud University Medical Center

  • Marieke de Laat, M.D. PhD · Radboud University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2029-06-01
Completion
2029-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06444607 on ClinicalTrials.gov